7 Penny Stocks to Buy on the Dip: February 2024

7 Penny Stocks to Buy on the Dip: February 2024

Trade SNDL on Coinbase

Now might be a good time to consider scooping up shares of penny stocks to buy on the dip. However, caution is essential, as penny stocks can be volatile and speculative. So to help reduce the risk to investors, I’ve chosen companies that seem to be on the safer side in terms of their fundamentals.

So here are seven penny stocks to buy on the dip for February.

BioNano Genomics (BNGO)

Bionano Genomics (BNGO) company logo on a website with blurry stock market developments in the background
Bionano Genomics (BNGO) company logo on a website with blurry stock market developments in the background

Source: Dennis Diatel / Shutterstock.com

BioNano Genomics (NASDAQ:BNGO) is a biotech stock that specializes in the analysis of genomic structures. I believe that now might be a good time to invest in BNGO stock. All as it builds from the momentum it started last year. As part of its product development pipeline, the company focused on advancing Optical Genome Mapping (OGM).

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

In addition, its financial outlook is attractive. BNGO expects to see a 27% to 30% increase in Q4 2023 revenues, quarter over quarter. It also expects its full-year revenue to increase by 29% to 30% from the previous year.  Wall Street is also bullish on BNGO stock as it predicts a 31.11% increase for its top line and a substantial increase in its EPS for the same period.

Tellurian (TELL)

Large tanker ship carrying natural gas at dusk in harbor
Large tanker ship carrying natural gas at dusk in harbor

Source: shutterstock.com/Wojciech Wrzesien

Another one of the top penny stocks to buy on the dip is Tellurian (NYSE:TELL), which is involved in the natural gas business, with a focus on LNG (liquefied natural gas) projects. I’m bullish on most LNG penny stocks, and TELL is no exception. It’s likely one of the better performers due to the construction of its Driftwood LNG project along with the production and sales of natural gas.

However, last quarter’s results for the company were a bit of a mixed bag. Tellurian reported increases in natural gas production when compared year-over-year for both the second and third quarters. Revenues, though, dipped 46.67% year-over-year to $43.25 million, and it also recorded a net income loss of $65 million.

TELL is still a buy in my eyes, though, as LNG production from its Driftwood site is expected to start in 2027 and could be highly accretive for the company. At just 47 cents per share. TELL offers investors a bargain valuation.

Zomedica (ZOM)

ZOM stock: Persian cat with veterinarian doctor at vet clinic
ZOM stock: Persian cat with veterinarian doctor at vet clinic

Source: didesign021 / Shutterstock.com

Zomedica (NYSE:ZOM) focuses on the development and commercialization of diagnostic products for pets. Like other other penny stocks to buy on this list, ZOM also reported strong financials last year.

The company anticipated fourth-quarter revenue to exceed $7 million, setting a new record, and overall annual revenue to surpass $25 million. That would mark a significant increase of over 32% from the previous year.  Much of the growth that ZOM experienced can be chalked up to a mix of its diagnostic sales and therapeutic devices, notably its PulseVet and Assisi products.